Lombard Medical Inc (NASDAQ:EVAR) announced its quarterly earnings results on Monday. The medical equipment provider reported $0.00 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.28. Lombard Medical had a negative net margin of 274.92% and a negative return on equity of 115.39%.
Shares of Lombard Medical (NASDAQ:EVAR) traded down 3.3006% during trading on Friday, hitting $0.5801. 51,765 shares of the stock traded hands. The company’s market cap is $11.54 million. Lombard Medical has a 52 week low of $0.50 and a 52 week high of $1.94. The firm’s 50-day moving average price is $0.68 and its 200-day moving average price is $0.71.
About Lombard Medical
Lombard Medical, Inc is a medical technology company. The Company specializes in developing, manufacturing, and marketing endovascular stent-grafts that address medical needs in the repair of aortic aneurysms. The Company’s Aorfix is an abdominal aortic aneurysm (AAA) stent-graft for the treatment of AAAs with angulation at the neck of the aneurysm of over 90 degrees.
Receive News & Ratings for Lombard Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lombard Medical Inc and related companies with MarketBeat.com's FREE daily email newsletter.